Gingicaine Gel, Chocolate Mint Gel
Product Images NDC 10129-034

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Gingicaine Gel, Chocolate Mint (NDC 10129-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gingi-pak A Division Of The Belport, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Keep Out Of Reach Of Children (Children Page 001)

Text panel with a safety warning for GingiCaine Gel stating it should be kept out of reach of children and advising to call a doctor immediately if GingiCaine is ingested or swallowed by a child, followed by directions to act accordingly.*

FDA Label Image

Contraindications

A drug facts text panel for GingiCaine Gel, Chocolate Mint Flavor. The visible section lists contraindications, stating it should not be used in patients with hypersensitivity to ester-type local anesthetics and is not for teething or use in children under 2 years.*

FDA Label Image

Gingicaine Chocolate Mint Jar Label

Drug Facts panel for GingiCaine Gel, Chocolate Mint, 20% Benzocaine Oral Anesthetic gel. The label details active ingredient, uses, allergy warnings, instructions to avoid use if tamper-evident sleeve is broken, comprehensive warnings including symptoms requiring medical attention, directions for anesthesia and dosage administration, and precautions. Manufacturer and product information, including NDC 10129-034-01 and net content 1 oz (30 gm), are also featured.*

FDA Label Image

Active Ingredient (Gingicaine Active Ingredients 001)

A text panel showing the active ingredient and purpose: Benzocaine 20% w/v as the oral anesthetic in GingiCaine Gel, Chocolate Mint flavor.*

FDA Label Image

Allergy Alert (Gingicaine Allergy Alert 002)

This image displays an allergy alert warning users not to use the product if they have a history of allergy to any 'caine' local anesthetics. It is a safety notice relevant for users of the product.*

FDA Label Image

Avoid Excessive Heat (Gingicaine Avoid Excessive Heat)

A warning text panel stating 'Avoid Excessive heat Above 40 °C (104 °F)', advising temperature conditions to avoid for the product storage or use.*

FDA Label Image

Consult A Doctor Promptly (Gingicaine Consult A Doctor)

A drug facts or warning text panel advising to consult a doctor promptly if sore throat symptoms worsen or persist beyond 2 days, or if accompanied by other conditions. It includes warnings about avoiding eye contact, keeping the product away from children, and instructions for accidental ingestion to seek medical help or poison control. It also cautions not to exceed the recommended dosage.*

FDA Label Image

Dosage And Administration001 (Gingicaine Dosage And Admin 001)

Text panel titled 'Dosage & Administration' describing instructions for drying mucosa prior to application and removal of excess saliva. The content appears to provide application guidelines for the product.*

FDA Label Image

Dosage And Administration002 (Gingicaine Dosage And Admin 002)

Text panel with directions for use of GingiCaine Gel, Chocolate Mint Flavor. Instructions include application method using sterile cotton or gauze, dosing frequency up to 4 times daily, precautions about dosage limits, and age guidelines specifying use for adults and children 2 years and older with advice for younger children to consult a dentist or doctor.*

FDA Label Image

Indications (Gingicaine Indications 001)

A text panel titled Indications describing the use of GingiCaine Gel for anesthesia of mucous membranes of the oropharynx. It minimizes pain from ulcers, needle punctures, deep scaling, and matrix band application, and aids in taking impressions or intraoral radiographs for patients with excessive gag reflex.*

FDA Label Image

Precautions (Gingicaine Precaution 001)

A text panel titled 'Precautions' for GingiCaine Gel, Chocolate Mint Flavor, advising dentists to avoid application on severely traumatized mucosal areas and certain regions of the posterior pharynx. It cautions on use in patients with drug sensitivities and avoiding contact with all local anesthetics to prevent sensitization.*

FDA Label Image

Uses (Gingicaine Uses 001)

Text panel titled 'Uses' listing the conditions that the product helps reduce pain or discomfort from, including minor dental procedures, minor gum injury, canker sores, sore throat, and minor mouth or gum irritations caused by dentures or orthodontic appliances.*

FDA Label Image

Inactive Ingredient (Inactive Ingredient Page 001)

A partial list of inactive ingredients for GingiCaine Gel, Chocolate Mint, including Polyethylene Glycol 3350, Polyethylene Glycol 400, and Potassium Sodium Saccharate.*

FDA Label Image

Purpose (Purpose Page 001)

Text panel describing Gingicaine Gel as a topical anesthetic used by dentists prior to injection, usually applied to a patient's gum. The text provides a brief explanation of the product's typical dental use.*

FDA Label Image

Warnings

A warning panel for GingiCaine Gel, Chocolate Mint Flavor, stating it is for external use only and may cause methemoglobinemia, a serious condition affecting oxygen in the blood. It lists symptoms requiring immediate medical attention, including cyanosis, headache, rapid heart rate, shortness of breath, dizziness, fatigue, and emphasizes not to use in children under 2 years of age.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.